Capstone Upgrades AMAG To Buy

by Lisa Levin, Benzinga Editor
February 2, 2011 7:18 AM | 12 seconds read |
Analysts at Capstone upgrade AMAG Pharmaceuticals Inc AMAG from “hold” to “buy.” The target price for AMAG is set to $21. AMAG shares fell 0.28% to close at $17.75 yesterday. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: UpgradesAnalyst RatingsCapstoneHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!